Actively Recruiting

Phase 3
Age: 18Years +
FEMALE
NCT06677554

Contribution of Contrast Enhanced Ultrasound for Diagnosis of Adnexal Torsion

Led by Central Hospital, Nancy, France · Updated on 2026-04-08

256

Participants Needed

6

Research Sites

142 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Adnexal torsion is the rotation of the ovary around its vascular axis resulting, in the absence of treatment, ischemia that can lead to peritonitis by necrosis or impaired fertility. It is a gynecological emergency affecting 3% of women of childbearing age, including from adolescence, and requires surgical treatment as soon as possible, classically within 6 hours. The symptomatology of adnexal torsion is dominated by pelvic pain of sudden onset and variable intensity, an aspecific sign that does not allow a diagnosis of certainty. There are no biological markers and, in the context of the emergency, the only imaging examination available is pelvic ultrasound associated with a Doppler flow analysis but with a low and variable diagnostic performance depending on the studies (sensitivity variable from 46 to 73%). There are currently no tests that can provide a diagnosis of certainty. Only surgical exploration, carried out at the discretion of the practitioner on the basis of a bundle of arguments, can confirm or refute the diagnosis. However, this management strategy leads to the realization of emergency surgical interventions wrongly since 3 out of 10 women will finally not have an adnexal torsion (PMSI data from participating centers: 30 to 45% false positives). Contrast ultrasound is a technique that uses a strict intravascular product to assess the vascularization of the ovary and offers a high diagnostic performance in the context of adnexal torsion. Indeed, a retrospective study, published in 2021, reports a sensitivity of 94% and a specificity of 100%. The preliminary results of our pilot study (AGATA APJC 2019, Dr Bertholdt, NCT04522219) also go in this direction with a sensitivity of 100%, a specificity of 86% and a negative predictive value of 100% (data being published). The COVARIAN project, second stage of the AGATA project, aims to demonstrate that the addition of a contrast evaluation to standard ultrasound in the diagnostic strategy in case of suspicion of adnexal torsion improves the health of women by reducing the rate of wrongly surgery, that is, without proven torsion. COVARIAN will be the first prospective multicenter randomized study evaluating the direct benefit for women of using ultrasound contrast evaluation in the management strategy in case of suspicion of adnexal torsion.

CONDITIONS

Official Title

Contribution of Contrast Enhanced Ultrasound for Diagnosis of Adnexal Torsion

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 or over
  • Completed a preliminary clinical examination suited for this trial
  • Strong suspicion of adnexal torsion with surgery planned
  • Not currently pregnant or breastfeeding
  • Affiliated with or beneficiary of a social security scheme
  • Received full information about the study and signed informed consent
Not Eligible

You will not qualify if you...

  • Does not understand or speak French
  • Any medical condition contraindicating SonoVue® administration, including:
    • Known allergy to sulphur hexafluoride or SonoVue® components
    • Acute coronary syndrome or unstable ischemic heart disease
    • Acute endocarditis
    • Presence of valve prostheses
    • Acute systemic inflammatory disease or sepsis
    • Hypercoagulation or recent thromboembolic event
    • End-stage kidney or liver disease
    • Right-left heart shunt or severe pulmonary hypertension (pulmonary arterial pressure > 90 mmHg)
    • Uncontrolled systemic hypertension
    • Respiratory distress syndrome
  • History of PEG (macrogol) allergy
  • Pregnant, giving birth, or breastfeeding
  • Minor or legally protected adult unable to consent
  • Person unable to give informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 6 locations

1

CHU

Besançon, France

Not Yet Recruiting

2

CHU

Dijon, France

Not Yet Recruiting

3

CHRU Nancy - Maternité Régionale

Nancy, France

Actively Recruiting

4

CHU

Reims, France

Not Yet Recruiting

5

CMCO

Schiltigheim, France

Not Yet Recruiting

6

CHU Hautepierre

Strasbourg, France

Not Yet Recruiting

Loading map...

Research Team

C

Charline BERTHOLDT, Pr

CONTACT

D

Dorine MANHERTZ, MSc

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here